© 2002 Journal of Medical Genetics
LETTER TO JMG
The frequency of mtDNA 8994 polymorphism and detection of the NARP 8993 mutation
Department of Clinical Chemistry, Diana, Princess of Wales Children's Hospital, Birmingham B4 6NH, UK
Correspondence to:
Correspondence to:
Dr R G F Gray, of Clinical Chemistry, Diana, Princess of Wales Children's Hospital, Birmingham B4 6NH, UK;
george.gray@bhamchildrens.wmids.nhs.uk
Keywords: NARP; mtDNA; 8994 polymorphism
The highly polymorphic nature of the mitochondrial genome (mtDNA) has proved valuable to the population geneticist, but can cause serious problems in the identification of disease causing mutations.
A T
C or T
G transition at nt 8993 in human mtDNA is associated with an array of clinical phenotypes including Neuropathy, Ataxia and Retinitis Pigmentosa (NARP)1 and Leigh's syndrome.2 Conventionally, it is detected by polymerase chain reaction (PCR) amplification of the region containing the mutant sequence followed by digestion with restriction enzymes HapII or HpaII (recognition sequence c
cgg) which recognise both sequence changes.1 The presence of either mutation results in the PCR product being cut into two fragments (343 bp and 206 bp), which can be separated and identified by agarose gel electrophoresis.
A polymorphic G
A transition in the adjacent base (nt 8994) abolishes the recognition site for the relevant restriction enzymes and, hence, in patients
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
